CHU Charles Nicolle

Rouen 76031

2 studies enrolling now · 12 studies all time

What they study most

Acute Respiratory Failure, Atherosclerotic Cardiovascular Disease (ASCVD), Crohn's Disease, Elevated Lp(a), Heart Failure, Heart Failure NYHA Class III and Ambulatory IV, Hemophilia A, Lamellar Ichthyosis, Melanoma, Obesity or Overweight, Parkinson Disease, Tachycardia

Studies at this site

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment — Enrolling by invitation
• A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma — Completed
• A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis — Stopped early
• A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment — Completed
• BAX 855 PK-guided Dosing — Completed
• Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Third International Study on Mechanical Ventilation — Completed
• Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) — Stopped early
• Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications — Completed